BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21647547)

  • 1. [Epidemiological and diagnostic axis I gender differences in dual diagnosis patients].
    Miquel L; Roncero C; López-Ortiz C; Casas M
    Adicciones; 2011; 23(2):165-72. PubMed ID: 21647547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dual diagnosis in psychoactive substance abusing or dependent persons].
    Błachut M; Badura-Brzoza K; Jarzab M; Gorczyca P; Hese RT
    Psychiatr Pol; 2013; 47(2):335-52. PubMed ID: 23888766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric referrals associated with substance use disorders: prevalence and gender differences. European Consultation-Liaison Workgroup.
    Alaja R; Seppä K; Sillanaukee P; Tienari P; Huyse FJ; Herzog T; Malt UF; Lobo A
    Alcohol Clin Exp Res; 1997 Jun; 21(4):620-6. PubMed ID: 9194914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases.
    Testa A; Giannuzzi R; Sollazzo F; Petrongolo L; Bernardini L; Dain S
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():65-85. PubMed ID: 23436669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual diagnosis in Spain.
    Gual A
    Drug Alcohol Rev; 2007 Jan; 26(1):65-71. PubMed ID: 17364838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual diagnosis in an Australian forensic psychiatric hospital: prevalence and implications for services.
    Ogloff JR; Lemphers A; Dwyer C
    Behav Sci Law; 2004; 22(4):543-62. PubMed ID: 15282839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of gender and diagnosis on addiction history, treatment utilization, and psychosocial functioning among a dually-diagnosed sample in drug treatment.
    Grella CE
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():169-79. PubMed ID: 12825760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of substance use disorder on the clinical presentation of anxiety and depression in an outpatient psychiatric clinic.
    Tsuang D; Cowley D; Ries R; Dunner DL; Roy-Byrne PP
    J Clin Psychiatry; 1995 Dec; 56(12):549-55. PubMed ID: 8530330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescent substance abuse and psychiatric comorbidities.
    Deas D
    J Clin Psychiatry; 2006; 67 Suppl 7():18-23. PubMed ID: 16961420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in abusers of amphetamine-type stimulants and ketamine in southwestern China.
    Zhang Y; Lu C; Zhang J; Hu L; Song H; Li J; Kang L
    Addict Behav; 2013 Jan; 38(1):1424-30. PubMed ID: 23006246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon.
    Karam EG; Yabroudi PF; Melhem NM
    Compr Psychiatry; 2002; 43(6):463-8. PubMed ID: 12439834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid psychiatric and alcohol abuse/dependence disorders: psychosocial stress, abuse, and personal history factors of those in treatment.
    De Bernardo GL; Newcomb M; Toth A; Richey G; Mendoza R
    J Addict Dis; 2002; 21(3):43-59. PubMed ID: 12094999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and prognostic characteristics associated with addictive comorbidity in hospitalized psychiatric patients].
    Liraud F; Verdoux H
    Encephale; 2000; 26(3):16-23. PubMed ID: 10951902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety disorders among patients with co-occurring bipolar and substance use disorders.
    Kolodziej ME; Griffin ML; Najavits LM; Otto MW; Greenfield SF; Weiss RD
    Drug Alcohol Depend; 2005 Nov; 80(2):251-7. PubMed ID: 15876498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-occurring mental illness and substance use disorder among Australian prisoners.
    Butler T; Indig D; Allnutt S; Mamoon H
    Drug Alcohol Rev; 2011 Mar; 30(2):188-94. PubMed ID: 21355926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patients with a diagnosis of pancreatitis and "dual diagnosis"].
    Just M; Ogłodek E
    Pol Merkur Lekarski; 2013 May; 34(203):298-301. PubMed ID: 23894784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.